Mays Cancer Ctr Uthsa Mdacc — San Antonio, Texas

Mays Cancer Ctr Uthsa Mdacc is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Mays Cancer Ctr Uthsa Mdacc has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors, Primary Immune Thrombocytopenia (ITP), Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mays Cancer Ctr Uthsa Mdacc?

Mays Cancer Ctr Uthsa Mdacc has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mays Cancer Ctr Uthsa Mdacc conducted?

Mays Cancer Ctr Uthsa Mdacc has 6 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Primary Immune Thrombocytopenia (ITP), Breast Cancer.

Is Mays Cancer Ctr Uthsa Mdacc accredited by Crixeo Health?

Mays Cancer Ctr Uthsa Mdacc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mays Cancer Ctr Uthsa Mdacc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.